Companies: | 51,220 |
Products and Services: | 2,875 |
Articles and publications: | 31,146 (+2) |
Tenders & Vacancies: | 17 |
August 16, 2021: The University of Minnesota has announced that it will begin collecting blood samples from a varied sample of 25,520 people throughout the country to understand better how early-life circumstances and experiences affect the later-life risk of Alzheimer's and other dementias and diagnose acute exacerbation of chronic obstructive pulmonary disease as per reports from Pillintrip.com.
The project, sponsored by $14.2 million in new NIA funding, introduces a unique component to the ongoing $28.4 million High School & Beyond (HS&B) study involving and expands on a $500,000 pilot study sponsored by the Alzheimer's Association in 2020.
The study for Analysis of blood biomarkers, based at the University of Minnesota's Minnesota Population Center (MPC), pulls together a national interdisciplinary team of top survey methodologists, neuropathologists, education scientists, sociologists, and neurologists. The newly financed component of the research aims to identify the biological mechanisms that lead to health disparities in cognitive impairment.
“There is research suggesting that socioeconomic and ethnic/racial disparities in late-life dementia rates have origins in disparities in academic experience and opportunity, childhood economic situations, and other early-life circumstances,” according to a Pillintrip.com representative.
About Pillintrip.com
Pillintrip.com is a website that gives comprehensive and up-to-date pharmacological information on medicine substitutability worldwide. Pillintrip.com is the only website of its kind that allows users to search for drug analogs from all over the world.
For more information, visit
###